Home > Healthcare > Medical Devices > Diagnostic Devices > Home Sleep Apnea Testing Devices Market

Home Sleep Apnea Testing Devices Market Share

Report ID: GMI4439
Published Date: Aug 2022
Report Format: PDF

Download Free Sample

Home Sleep Apnea Testing Devices Market Share

Compumedics Limited
Itamar Medical Inc
Natus Medical Inc
SOMNOmedics GmbH
Koninklijke Philips N.V
Resmed
Nox Medical

are some of the key home sleep apnea testing devices market players. These companies are mainly focusing on tapping into the latest technologies and expanding their product portfolio to strengthen their position in the market. For example, in September 2019, Philips announced the commercial launch of a prescription sleep position therapy device, NightBalance, for patients with positional obstructive sleep apnea. It also introduced a positional therapy that uses gentle vibrations to alter sleeping positions to help prevent apneas.

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

The global market for home sleep apnea testing devices crossed USD 810 million in 2021 and is set to depict a CAGR of 16.8% through 2030.

The type 3 segment accounted for 65% of the home sleep testing devices industry share in 2021 and will be valued over USD 2,240 million by 2030, owing to its attributes such as portability, ease of use, and high sensitivity and specificity.

North America’s home sleep apnea testing devices industry will be valued at USD 1,100 million by 2030, due to the high prevalence of sleep disorders and awareness of early-stage diagnosis.

The competitive landscape of the home sleep apnea testing devices industry is inclusive of companies such as Koninklijke Philips N.V., Compumedics Limited, Itamar Medical Inc., Natus Medical Inc., SOMNOmedics GmbH, Resmed, and Nox Medical, among others.